drugset
drugset / Trial / NCT05347758

A Phase I Single- and Multiple- Ascending Dose and Food Effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7535 in Healthy Subjects

NCT05347758 ↗

Phase 1 Unknown 106 enrolled Shandong Suncadia Medicine Co., Ltd.
RandomizedSequentialTriple-blindOther

Summary

This is a randomized, double-blinded, placebo-controlled study to evaluate the safety, tolerability, Pharmacokinetics and Pharmacodynamics of single ascending dose (Part A) and multiple ascending dose (Part B) of HRS-7535 in healthy subjects.

Timeline

Start
2022-05-01
Primary completion
2022-09-18
Completion
2023-03-15

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-7535 Small molecule — —

Indications

No indication recorded.